Health effectiveness and cost-effectiveness of telehealthcare for heart failure: study protocol for a randomized controlled trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Health effectiveness and cost-effectiveness of telehealthcare for heart failure: study protocol for a randomized controlled trial ; volume:17 ; number:1 ; day:12 ; month:12 ; year:2016 ; pages:1-6 ; date:12.2016
Trials ; 17, Heft 1 (12.12.2016), 1-6, 12.2016
- Creator
-
Cichosz, Simon Lebech
- Contributor
-
Ehlers, Lars Holger
Hejlesen, Ole
SpringerLink (Online service)
- DOI
-
10.1186/s13063-016-1722-5
- URN
-
urn:nbn:de:1111-201701085091
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cichosz, Simon Lebech
- Ehlers, Lars Holger
- Hejlesen, Ole
- SpringerLink (Online service)
Other Objects (12)
Strategies for cost-effectiveness analysis of rehabilitation for older patients with acute heart failure
Clinical effectiveness and cost-effectiveness of ambulatory heart failure nurse-led services: an integrated review
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness Models for Pharmacologic Interventions in Adults with Heart Failure: A Systematic Literature Review
Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes
A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction
Accounting for Moral Hazard In Cost-Effectiveness Analysis
Cost-Effectiveness Analysis of Qsymia for Weight Loss
Cost-effectiveness of digital therapeutics for essential hypertension
Online Cost-Effectiveness ANalysis (OCEAN): a user-friendly interface to conduct cost-effectiveness analyses for cervical cancer
Strategies for cost-effectiveness analysis of rehabilitation for older patients with acute heart failure
Clinical effectiveness and cost-effectiveness of ambulatory heart failure nurse-led services: an integrated review
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness Models for Pharmacologic Interventions in Adults with Heart Failure: A Systematic Literature Review
Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes
A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction
Accounting for Moral Hazard In Cost-Effectiveness Analysis
Cost-Effectiveness Analysis of Qsymia for Weight Loss
Cost-effectiveness of digital therapeutics for essential hypertension
Online Cost-Effectiveness ANalysis (OCEAN): a user-friendly interface to conduct cost-effectiveness analyses for cervical cancer
Strategies for cost-effectiveness analysis of rehabilitation for older patients with acute heart failure
Clinical effectiveness and cost-effectiveness of ambulatory heart failure nurse-led services: an integrated review
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness Models for Pharmacologic Interventions in Adults with Heart Failure: A Systematic Literature Review
Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes
A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction
Accounting for Moral Hazard In Cost-Effectiveness Analysis
Cost-Effectiveness Analysis of Qsymia for Weight Loss
Cost-effectiveness of digital therapeutics for essential hypertension